Evanson Asset Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Evanson Asset Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-20	Closed	-$25K	–	212
2016 Q1	$25K	Hold	20	–	–	0.01%	196
2015 Q4	$26K	Hold	20	–	–	0.01%	196
2015 Q3	$29K	Hold	20	–	–	0.01%	202
2015 Q2	$44K	Hold	20	–	–	0.02%	211
2015 Q1	$60K	Hold	20	–	–	0.02%	192
2014 Q4	$66K	Hold	20	–	–	0.02%	185
2014 Q3	$71K	Hold	20	–	–	0.03%	181
2014 Q2	$77K	Hold	20	–	–	0.03%	188
2014 Q1	$81K	Hold	20	–	–	0.04%	173
2013 Q4	$74K	Buy	+20	New	+$75.8K	0.03%	168

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Evanson Asset Management's FRTX Position: Q2 2016 in Review

Evanson Asset Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2016, closing a stake of 20 shares — an estimated $25K sold.

Evanson Asset Management first reported a position in FRTX in Q4 2013 and held it in 10 quarters. The position peaked at $81K in Q1 2014. 36 funds tracked by Wall St. Rank hold FRTX as of Q2 2016.

Evanson Asset Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Evanson Asset Management sold 20 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $25K.
Evanson Asset Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 10 quarters.
Evanson Asset Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $81K in Q1 2014.
36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Evanson Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.